Related Articles
NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia
TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells
BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
Salidroside inhibits chronic myeloid leukemia cell proliferation and induces apoptosis by regulating the miR‑140‑5p/wnt5a/β‑catenin axis
Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinib‑based therapy